Ignite Creation Date:
2024-05-05 @ 11:22 PM
Last Modification Date:
2024-10-26 @ 10:32 AM
Study NCT ID:
NCT01314170
Status:
UNKNOWN
Last Update Posted:
2011-05-10
First Post:
2010-08-04
Brief Title:
Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma
Sponsor:
Adapt Produtos Oftalmológicos Ltda
Organization:
Adapt Produtos Oftalmológicos Ltda
Study Overview
Official Title:
Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma
Status:
UNKNOWN
Status Verified Date:
2011-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study clinical multicenter phase III open-label prospective character to evaluate the efficacy and safety Susanna Implant in patients with refractory glaucoma
Detailed Description:
Clinical trial multicenter phase IIIopen-label prospective character to evaluate the efficacy and safety of Susanna Implant in patients with refractory glaucoma of both genders of any race aged above 18 years and diagnosed with glaucoma refractory
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None